Introduction Bronchopulmonary dysplasia (BPD) remains a major complication among extremely low gestational age (ELGA) infants ...

Casgevy sickle cell gene therapy is now FDA-approved for children as young as two, opening access for 5,500 more U.S. kids.

People living with hereditary angioedema, a rare genetic condition that triggers sudden, painful swelling of the face, throat ...

Primary bone tumors, such as osteosarcoma, have seen stagnant survival rates over the past four decades. Surgical removal of the tumor is critical, but local recurrence may occur when tumours are ...

CRISPR Therapeutics wins FDA pediatric approval for Casgevy, boosting market potential and pipeline upside despite slow uptake. Click here to read more.

The FDA on Wednesday expanded the approval for exagamglogene autotemcel (exa-cel, Casgevy) in severe sickle cell disease with ...

In patients with fibrodysplasia ossificans progressiva, an oral selective inhibitor of activin receptor–like kinase 2 was ...

I’m currently in the final stages of recovering from osteonecrosis of the jaw (ONJ). Getting a diagnosis took two months, all ...

Researchers developed an experimental osteoarthritis injection that repaired damaged cartilage and regenerated joints in ...

ONJ is a rare side-effect of denosumab (Prolia), with one large trial finding the equivalent of about five cases per 1,000 ...

I'm currently in the final stages of recovering from osteonecrosis of the jaw (ONJ). Getting a diagnosis took two months, all ...